Market Herald logo

Subscribe

Be the first with the news that moves the market
  • Pro Medicus (PME) subsidiary Visage Imaging has signed a $14 million, eight-year contract with the University of Vermont Health Network
  • The contract will see the company’s Visage 7 diagnostic imaging platform implemented across the university’s six hospitals
  • Notably, Visage 7 will be fully deployed in the public cloud
  • Planning for the rollout is set to commence immediately, with initial “go-lives” targeted for the second half of the calendar year
  • Pro Medicus shares are up 1.45 per cent, trading at $41.15 cents each

Pro Medicus’ (PME) wholly owned subsidiary Visage Imaging has signed a $14 million, eight-year contract with the University of Vermont Health Network.

Based on a transactional licensing model, the contract will see the company’s Visage 7 enterprise diagnostic imaging platform implemented across UVM’s six hospitals.

Notably, the University’s medical centre in Burlington, Vermont, is the teaching hospital for The Larner College of Medicine.

Pro Medicus CEO Dr Sam Hupert said the platform would be deployed in the public cloud.

“We continue to build momentum in the market with this, our seventh contract win in a row, adding to other recent major announcements,” Dr Hupert said

“UVM Health Network is the fourth of these to opt for a cloud-based solution, a trend we see increasing rapidly amongst healthcare systems in North America.”

“Visage 7, with its proven cloud-native capability provides us with a significant strategic advantage that enables us to address these opportunities across a growing segment of the market both in North America and other regions.”

Planning for the rollout is set to commence immediately, with initial “go-lives” targeted for the second half of the calendar year.

On the back of the announcement, Pro Medicus shares are trading 1.45 per cent higher at $41.15 cents at 12:34 pm AEST.

PME by the numbers
More From The Market Herald
EBR Systems (ASX:EBR) - President & CEO, John McCutcheon

" EBR Systems (ASX:EBR) completes interim enrolment for SOLVE trial

EBR Systems (ASX:EBR) has completed interim patient enrolment in the pivotal SOLVE-CRT IDE trial of WiSE.
The Market Herald Video

" Nuheara (ASX:NUH) partners with Realtek to target hearing-related markets

Nuheara (ASX:NUH) has announced a strategic partnership and cornerstone investment from Taiwan-based Realtek Semiconductor Corporation via…
The Market Herald Video

" Paradigm Biopharmaceuticals (ASX:PAR) completes recruitment for knee OA trial

Paradigm Biopharmaceuticals (ASX:PAR) completes recruitment for its phase two clinical trial for treating knee osteoarthritis.

" Nanoveu (ASX:NVU) signs MoU to establish JV in India

Nanoveu (ASX:NVU) has signed a memorandum of understanding (MoU) with Alan Scott Industries to establish a…